PARIS – After two years steadily announcing new contracts for proton therapy systems worldwide and attracting investors who accelerated its stock valuation 360 percent, Ion Beam Applications SA (IBA) has hit a wall, reporting that half of its installation projects have been delayed, choking revenue generation.